RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 34-44
  • Arrowhead Research seeks to reassure antsy investors

    Arrowhead Research seeks to reassure antsy investors
    Arrowhead Research Corp. is trying to succeed where major pharmaceutical company efforts have failed in finding a cure for one of the world's most tenacious diseases. The Pasadena biopharmaceutical company is developing so-called RNAi therapeutics. Such...
  • Payments to doctors from drug companies, device makers revealed

    Payments to doctors from drug companies, device makers revealed
    Late last year, medical device maker Zimmer Holdings Inc. made two large payments to Dr. Andrew N. Pollak, chair of the University of Maryland Medical System's orthopedics department. The payments, one for $47,225 and the other for $45,902, were...
  • Pacific Pact Could Hurt Drug Innovation, Drug Makers

    Pacific Pact Could Hurt Drug Innovation, Drug Makers
    This month, negotiations over the Trans-Pacific Partnership resume in Australia. Officials from the United States and 11 other major economies are meeting to settle the final details of the trade pact, with the hope of passing the final deal by year's...
  • Madelyn Butler: Dressing up pot as medicine doesn't cut it

    Madelyn Butler: Dressing up pot as medicine doesn't cut it
    The relationship between a doctor and a patient is a sacred trust and a legal bond. One of the most common treatments that doctors provide to patients is to prescribe medications. When writing a prescription, the doctor stipulates a specific medication,...
  • Salix Pharmaceuticals drops tax inversion deal amid backlash

    Salix Pharmaceuticals drops tax inversion deal amid backlash
    Salix Pharmaceuticals called off its merger with a foreign drug maker Friday, citing the political backlash against tax inversion deals. The deals—in which a company reincorporates abroad to gain lower taxes—drew fire this summer after...
  • Nazareth police undercover drug buy nets heroin, pills and synthetic marijuana

    Nazareth police undercover drug buy nets heroin, pills and synthetic marijuana
    Nazareth police said an undercover drug buy Wednesday netted more than 50 bags of heroin, prescription painkillers and synthetic marijuana. Pedro Alexander Vera, 25, of the 1200 block of Livingston Street, Bethlehem, is charged with manufacturing...
  • Allergan is in merger talks with Irish pharmaceutical firm Actavis

    Allergan is in merger talks with Irish pharmaceutical firm Actavis
    Botox maker Allergan Inc. of Irvine, which has spent six months fighting a hostile takeover attempt by a Canadian company, is in increasingly serious discussions to merge with Irish pharmaceutical firm Actavis. If Allergan agrees to be acquired by...
  • Activist investor Bill Ackman wants auction for Allergan

    Activist investor Bill Ackman wants auction for Allergan
    Activist hedge fund manager Bill Ackman on Friday urged Botox maker Allergan Inc. to put itself up for auction. The request follows Allergan’s disclosure that it is in talks to potentially merge with a firm other than the Canadian company Ackman...
  • Allergan, fighting off Valeant, discussing merger with another firm

    Allergan, fighting off Valeant, discussing merger with another firm
    Botox maker Allergan Inc. said it’s discussing a merger with an unnamed firm as it battles a hostile takeover by Valeant Pharmaceuticals. For six months Irvine-based Allergan has fought off an unsolicited takeover bid from Valeant...
  • Hospira profit soars despite loss of drug exclusivity

    Hospira profit soars despite loss of drug exclusivity
    Lake Forest-based drugmaker Hospira's profit skyrocketed in the third quarter compared with the same period a year earlier, mainly because of the sale of its clinical surveillance software business, Theradoc. Net income rose to $158.6 million, or 92...
  • OraSure expects milestones in its Ebola research

    OraSure expects milestones in its Ebola research
    By the end of the year, Bethlehem-based OraSure expects to announce key research milestones in determining if its OraQuick rapid in-home HIV test can be adapted to screen patients for Ebola. The company has consulted with the federal Food and Drug...